| linkage analysis of geographic and clinical clusters in pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. | multilocus enzyme electrophoresis and ribotyping were used to characterize 83 strains of pseudomonas cepacia, mostly isolated from cystic fibrosis (cf) patients, although a number of isolates from non-cf nosocomial infections and reference environmental strains were represented. twenty enzyme electrophoretic types (ets) were determined; of these, one clone (et12) was associated with six of nine ribotypes (rts) said to be geographically representative of the united kingdom and all of the ontario ... | 1994 | 7517953 |
| epidemiology of burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic dna fingerprinting. | we fingerprinted a collection of 627 burkholderia cepacia isolates from 255 patients with cystic fibrosis (cf) and 43 patients without cf and from the environment, by a pcr-based randomly amplified polymorphic dna (rapd) method with primers selected for their ability to produce discriminatory polymorphisms. the rapd typing method was found to be reproducible and discriminatory, more sensitive than pcr ribotyping, and able to group epidemiologically related b. cepacia strains previously typed by ... | 1996 | 8940422 |
| burkholderia species infections in patients with cystic fibrosis in british columbia, canada. 30 years' experience. | we have been collecting burkholderia species bacteria from patients with cystic fibrosis (cf) for the last 30 years. during this time, our understanding of their multispecies taxonomy and infection control has evolved substantially. | 2015 | 25474359 |
| infection with burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar iii can replace burkholderia multivorans. | infection with burkholderia cepacia complex in patients with cystic fibrosis (cf) results in highly variable clinical outcomes. the purpose of this study was to determine if there are genomovar-specific disparities in transmission and disease severity. b. cepacia complex was recovered from 62 patients with cf on > or =1 occasions (genomovar iii, 46 patients; genomovar ii [b. multivorans], 19 patients; genomovar iv [b. stabilis], 1 patient; genomovar v [b. vietnamiensis], 1 patient; and an unclas ... | 2001 | 11588691 |